نتایج جستجو برای: transplantation hsct

تعداد نتایج: 143542  

Journal: :Sovremennaâ Revmatologiâ 2021

Autologous hematopoietic stem cell transplantation (auto-HSCT) is presently the only disease-modifying strategy for treatment of systemic sclerosis (SSs) that has Level A evidence, effectiveness which been proven in three controlled clinical trials: ASSIST, ASTIS, and SCOT. Despite positive results obtained with use this option, issues related to its tolerability safety remain unresolved. The c...

2017
Jiun-Nong Lin Hsuan-Ju Chen Chih-Hui Yang Chung-Hsu Lai Hsi-Hsun Lin Chao-Sung Chang Ji-An Liang

BACKGROUND Long-term data on post-hematopoietic stem cell transplantation (HSCT) osteoporosis and fracture are limited. This study evaluated the long-term risk of osteoporosis and fracture in cancer patients who underwent HSCT. RESULTS The incidence density rate of osteoporosis was 12.5 per 1000 person-years in the HSCT group, which was significantly higher than that in the non-HSCT group (5....

Journal: :The new microbiologica 2012
Erika Biral Maura Faraci Edoardo Lanino Giuseppe Morreale Stefano Giardino Cristina Moroni Giuseppe Losurdo Gian Michele Magnano Evelina Senno Elio Castagnola

Pulmonary infections often complicate hematopoietic stem cell transplantation (HSCT) outcome. Uncommon aetiologies, like Mycobacterium tuberculosis, should be considered when the clinical conditions do not fully improve with standard antimicrobial therapy and microbiological evaluations are repeatedly negative for bacteria and fungi. We describe an interesting pediatric case of miliary lung tub...

2017
Seung-Ah Yahng Myungshin Kim Tae-Min Kim Young-Woo Jeon Jae-Ho Yoon Seung-Hwan Shin Sung-Eun Lee Ki-Seong Eom Seok Lee Chang-Ki Min Hee-Je Kim Dong-Wook Kim Jong-Wook Lee Woo-Sung Min Yoo-Jin Kim

Hypomethylating treatment (HMT) has been suggested as a feasible bridge to hematopoietic stem cell transplantation (HSCT), but controversies exist around influences of HMT response on transplant outcomes. To assess the safety and influences of pre-transplant HMT focusing on debulking effects and transplant outcomes, we retrospectively analyzed consecutive HSCT-eligible patients who received HMT...

2017
Martin Solders Tom Erkers Laia Gorchs Thomas Poiret Mats Remberger Isabelle Magalhaes Helen Kaipe

Mucosal-associated invariant T (MAIT) cells are innate-like T cells which are important in the defense against certain bacteria and yeast. The reconstitution of MAIT cells after allogeneic hematopoietic stem cell transplantation (HSCT) is not known. We investigated MAIT cell phenotype and function in 17 patients devoid of relapse and severe graft-versus-host disease (GvHD) in paired samples col...

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015
Roni Shouval Myriam Labopin Ori Bondi Hila Mishan-Shamay Avichai Shimoni Fabio Ciceri Jordi Esteve Sebastian Giebel Norbert C Gorin Christoph Schmid Emmanuelle Polge Mahmoud Aljurf Nicolaus Kroger Charles Craddock Andrea Bacigalupo Jan J Cornelissen Frederic Baron Ron Unger Arnon Nagler Mohamad Mohty

PURPOSE Allogeneic hematopoietic stem-cell transplantation (HSCT) is potentially curative for acute leukemia (AL), but carries considerable risk. Machine learning algorithms, which are part of the data mining (DM) approach, may serve for transplantation-related mortality risk prediction. PATIENTS AND METHODS This work is a retrospective DM study on a cohort of 28,236 adult HSCT recipients fro...

Journal: :Blood 2007
André Tichelli Christoph Bucher Alicia Rovó Georg Stussi Martin Stern Michael Paulussen Jörg Halter Sandrine Meyer-Monard Dominik Heim Dimitrios A Tsakiris Barbara Biedermann Jakob R Passweg Alois Gratwohl

We assessed incidence and risk factors of cardiovascular events in 265 patients undergoing allogeneic hematopoietic stem-cell transplantation (HSCT) between 1980 and 2000 and who survived at least 2 years. Results were compared with a cohort of 145 patients treated during the same period with autologous HSCT. The median age of patients with allogeneic HSCT at last follow-up was 39 years, and me...

2014
Jun Aoki Kiminori Kimura Kazuhiko Kakihana Kazuteru Ohashi Hisashi Sakamaki

INTRODUCTION Hepatitis B virus (HBV) flare is a serious problem following hematopoietic stem cell transplantation (HSCT), and the mortality rate is high if severe hepatitis occurs. CASE DESCRIPTION Although Entecavir (ETV) is a standard antiviral drug for HBV infection, the efficacy and safety of ETV therapy in HSCT are still unclear. DISCUSSION AND EVALUATION To examine the efficacy and to...

2010
Vinod Pullarkat

Recipients of hematopoietic stem cell transplantation (HSCT) frequently have iron overload resulting from chronic transfusion therapy for anemia. In some cases, for example, in patients with myelodysplastic syndromes and thalassemia, this can be further exacerbated by increased absorption of iron from the gut as a result of ineffective erythropoiesis. Accumulating evidence has established the n...

2014
T. M. Haverman J. E. Raber-Durlacher W. M. H. Rademacher S. Vokurka J. B. Epstein C. Huisman M. D. Hazenberg J. J. de Soet J. de Lange F. R. Rozema

Hematopoietic stem cell transplantation (HSCT) is widely used as a potentially curative treatment for patients with various hematological malignancies, bone marrow failure syndromes, and congenital immune deficiencies. The prevalence of oral complications in both autologous and allogeneic HSCT recipients remains high, despite advances in transplant medicine and in supportive care. Frequently en...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید